DL-Menthol [89-78-1]
Referencia NB-64-18671-5g
embalaje : 5g
Marca : Neo Biotech
DL-Menthol (Synonyms: Hexahydrothymol, 15356-70-4, (±)-Menthol)
Catalog No. T2979 Copy Product Info
Purity: 99.74%
DL-Menthol ((±)-Menthol) is a racemic mixture of the monoterpene alcohols (–)-menthol and (+)-menthod, which have been found in Cannabis. (–)-Menthol is more common than (+)-menthol in nature and exhibits analgesic, antibacterial, and anticancer properties, as well as inhibits cholinesterase.2 (+)-Menthol inhibits the growth of F. verticillioides (MIC: 1.5 mM) but, unlike (–)-menthol, does not exhibit analgesic, antibacterial, anticancer, or cholinesterase inhibitory activities.
DL-Menthol
Copy Product InfoSynonyms Hexahydrothymol, 15356-70-4, (±)-Menthol
DL-Menthol ((±)-Menthol) is a racemic mixture of the monoterpene alcohols (–)-menthol and (+)-menthod, which have been found in Cannabis. (–)-Menthol is more common than (+)-menthol in nature and exhibits analgesic, antibacterial, and anticancer properties, as well as inhibits cholinesterase.2 (+)-Menthol inhibits the growth of F. verticillioides (MIC: 1.5 mM) but, unlike (–)-menthol, does not exhibit analgesic, antibacterial, anticancer, or cholinesterase inhibitory activities.

Cas No. 89-78-1
Product Introduction
DL-Menthol AI Summary
DL-Menthol is a multifaceted molecule demonstrating various bioactivities. It functions as an inhibitor of COX2, showing an inhibition rate of less than 30.0% at 100 μM and 60.0% at 0.1 μg/mL. The compound is active in the expressed human recombinant enzymes UGT1A4 and UGT2A1, with activities recorded at 41.0 pm/min/mg and 32.0 pm/min/mg, respectively. It also exhibits lytic activity against Monographella nivalis var. nivalis MAFF 305031, causing 45.7% hyphal lysis at 0.2 mg/ml after 48 hours. Additionally, DL-Menthol acts as an agonist at TRPM8 in differentiated rat/mouse F11 cells and in human TRPM8 receptors, with EC50 values of 23400.0 nM and 10100.0 nM, respectively. It also activates human TRPA1 receptors with an EC50 of 96000.0 nM. Its agonist activity extends to the N-terminal rat ST3 receptor-fused human TAS2R7 in HEK293T cells, indicating calcium signaling in a concentration-dependent manner up to 2.60 mM. Further bioactivities include inhibition of human Apurinic/apyrimidinic Endonuclease 1 (APE1) at 50.1 nM, and Cav1.2 calcium current in rabbit ventricular myocytes with an IC50 of 74600.0 nM. It acts as an antagonist on human OR5K1 in HEK293 cells, inhibiting the response to 2,6-dimethylpyrazine by at least 50.0% at 100 μM. Despite these activities, DL-Menthol has limited effect on the SARS-CoV-2 3CL-Pro protease and SARS-CoV-2 induced cytotoxicity of VERO-6 cells. The compound shows minimal antiviral activity with an 11.1% inhibition of the 3CL-Pro protease at 20 μM and a -0.18% inhibition of cytotoxicity at 10 μM. Activity assays on human HDAC6 report low inhibition rates of 2.89% and -3.28% depending on the substrate used. Lastly, although tested extensively, the compound displayed no significant activity in assays with AC50 values exceeding 30,000.0 nM..
Note: Summary generated by AI. Data source: ChEMBL 
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | DL-Menthol ((±)-Menthol) is a racemic mixture of the monoterpene alcohols (–)-menthol and (+)-menthod, which have been found in Cannabis. (–)-Menthol is more common than (+)-menthol in nature and exhibits analgesic, antibacterial, and anticancer properties, as well as inhibits cholinesterase.2 (+)-Menthol inhibits the growth of F. verticillioides (MIC: 1.5 mM) but, unlike (–)-menthol, does not exhibit analgesic, antibacterial, anticancer, or cholinesterase inhibitory activities. |
| Synonyms | Hexahydrothymol, 15356-70-4, (±)-Menthol |
| Molecular Weight | 156.27 |
| Formula | C10H20O |
| Cas No. | 89-78-1 |
| Smiles | [C@H](C)(C)[C@H]1[C@H](O)C[C@H](C)CC1 |
| Relative Density. | 0.89 |
| Storage | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | Ethanol: Soluble H2O: Insoluble DMSO: 245 mg/mL (1567.8 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||


